LGBTQ Loyalty (LFAP) 10-Q 16 Nov 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2020	Nov. 14, 2020
Cover [Abstract]
Entity Registrant Name	LGBTQ Loyalty Holdings, Inc.
Entity Central Index Key	0001510247
Document Type	10-Q
Document Period End Date	Sep. 30, 2020
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business Flag	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		214,614,749
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2020

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Current assets:
Cash	$ 243,902	$ 13,188
Other receivables	100,000	100,000
Other current assets	6,925	9,220
Total current assets	350,827	122,408
Property and equipment, net	1,800	1,800
Intangible assets, net	84,733	73,076
Total assets	437,360	197,284
Current liabilities:
Accounts payable	1,017,090	772,065
Accrued salaries and consulting fees	399,696	650,133
Accrued interest and dividends	171,588	71,212
Notes payable	128,986	82,986
Notes payable to related party	66,560	17,885
Convertible notes payable, net of debt discount	944,379	363,769
Derivative liability on convertible notes payable	1,291,732	1,111,879
Total liabilities	4,020,031	3,069,929
Commitments and contingencies
Stockholders' equity (deficit):
Common stock, $0.001 par value, 1,000,000,000 shares authorized, 216,698,082 and 169,217,460 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively	216,699	169,217
Additional paid-in capital	7,091,797	6,035,547
Accumulated deficit	(10,891,347)	(9,077,614)
Total stockholders' equity (deficit)	(3,582,671)	(2,872,645)
Total liabilities and stockholders' equity (deficit)	437,360	197,284
Series A Preferred Stock [Member]
Stockholders' equity (deficit):
Preferred stock
Total stockholders' equity (deficit)
Series B Preferred Stock [Member]
Stockholders' equity (deficit):
Preferred stock	50	75
Total stockholders' equity (deficit)	50	75
Series C Preferred Stock [Member]
Stockholders' equity (deficit):
Preferred stock	130	130
Total stockholders' equity (deficit)	$ 130	$ 130

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2020	Dec. 31, 2019
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	216,698,082	169,217,460
Common stock, shares outstanding	216,698,082	169,217,460
Series A Preferred Stock [Member]
Preferred stock, shares authorized	1	1
Preferred stock, shares issued
Preferred stock, shares outstanding
Series B Preferred Stock [Member]
Preferred stock, shares authorized	500,000	500,000
Preferred stock, shares issued	50,000	75,000
Preferred stock, shares outstanding	50,000	75,000
Series C Preferred Stock [Member]
Preferred stock, shares authorized	129,559	129,559
Preferred stock, shares issued	129,559
Preferred stock, shares outstanding	129,559

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Statement [Abstract]
Revenue		$ 748	$ 560	$ 2,812
Cost of net revenue
Gross profit		748	560	2,812
Operating expenses:
Personnel costs	60,979	119,608	560,441	1,017,275
Consulting fees	93,444	375,041	261,459	479,062
Legal and professional fees	140,873	36,606	363,216	215,967
Merger costs				388,675
Sales and marketing	25,392	31,989	32,982	41,739
General and administrative	89,698	118,667	160,424	165,818
Depreciation and amortization	6,448	100	19,344	100
Total operating expenses	416,834	682,011	1,397,866	2,308,636
Loss from operations	(416,834)	(681,263)	(1,397,306)	(2,305,824)
Other income (expense):
Interest expense	(436,939)	(199,170)	(1,174,251)	(1,384,782)
Other income			3,000
Change in derivative liability	481,046	(225,593)	805,918	(492,401)
Total other income (expense), net	44,107	(424,763)	(365,333)	(1,877,183)
Provision for income taxes
Net loss	$ (372,727)	$ (1,106,026)	$ (1,762,639)	$ (4,183,007)
Net loss per common share - basic and diluted	$ 0	$ (0.01)	$ (0.01)	$ (0.02)
Weighted average common shares outstanding - basic and diluted	214,661,045	163,569,530	196,571,521	234,277,621

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net loss	$ (1,762,639)	$ (4,183,007)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt discount and original issue discount	584,445	124,660
Change in fair value of derivative liability	(805,918)	492,401
Financing related costs - debt	471,328	1,272,879
Merger expenses		388,675
Stock-based compensation expense	213,276	562,901
Officer deferred compensation		109,331
Depreciation and amortization	19,344	100
Changes in operating assets and liabilities:
Accounts payable	245,024	232,247
Accrued salaries and consulting fees	369,960	115,682
Accrued interest and dividends	100,377	37,435
Net cash used in operating activities	(564,803)	(846,796)
Cash flows from investing activities:
Purchases of property and equipment		(2,000)
Investment in intangible assets	(31,000)	(47,500)
Net cash used in investing activities	(31,000)	(49,500)
Cash flows from financing activities:
Proceeds from issuance of convertible debenture agreements	637,000	700,000
Net proceeds (repayments) from promissory note agreements	96,175	(7,088)
Proceeds from Series B preferred stock		125,000
Proceeds from exercise of warrants	93,342	51,569
Net cash provided by financing activities	826,517	869,481
Net increase (decrease) in cash	230,714	(26,815)
Cash at beginning of period	13,188	40,908
Cash at end of period	243,902	14,093
Supplemental disclosure of cash flow information:
Cash paid for income taxes
Cash paid for interest	27,500
Supplemental disclosure of non-cash financing activities:
Conversion of accrued consulting fees into common shares	617,750	348,312
Exercise of common stock warrants - derivative liability	32,742
Amortization of preferred stock discount	45,056
Exercise of options	10,400
Conversion of notes payable	15,000	98,383
Warrants issued in connection with debt	$ 41,396

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Series A Preferred Stock [Member]	Series B Preferred Stock [Member]	Series C Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Deferred Compensation [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2018				$ 121,984	$ 3,242,449	$ (195,054)	$ (3,880,234)	$ (710,855)
Balance, shares at Dec. 31, 2018				121,984,192
Merger with Maxim Partners				$ 129,559	259,116			388,675
Merger with Maxim Partners, shares	1			129,558,574
Common shares issued for related party debt conversions				$ 8,600	339,712			348,312
Common shares issued for related party debt conversions, shares				8,600,298
Maxim exchange agreement	$ (1)		$ 129,559	$ (129,559)				0
Maxim exchange agreement, shares			129,559	(129,558,574)
Common shares issued pursuant to note conversions				$ 26,587	750,773			777,360
Common shares issued pursuant to note conversions, shares				26,586,234
Common shares issued for services performed				$ 5,250	557,651			562,901
Common shares issued for services performed, shares				5,250,000
Exercise of stock options				$ 500	4,500			5,000
Exercise of stock options, shares				500,000
Debenture conversions				$ 427	45,620			$ 46,047
Debenture conversions, shares				427,500				427,500
Exercise of common stock warrants				$ 1,405	116,155			$ 117,560
Exercise of common stock warrants, shares				1,405,000
Issuance of Series B dividend shares				$ 17	1,421			1,438
Issuance of Series B dividend shares, shares				16,794
Issuance of Series B preferred stock, net of discount		$ 125			124,875			125,000
Issuance of Series B preferred stock, net of discount, shares		125,000
Conversion of Series B preferred stock		$ (25)		$ 735	(710)
Conversion of Series B preferred stock, shares		(25,000)		734,918
Amortization and revaluation of preferred stock discount					9,301		(9,301)
Amortization of preferred stock discount					11,201		(11,201)
Dividends on preferred stock						(8,338)		(8,338)
Amortization of deferred compensation						152,644		152,644
Net loss							(4,183,007)	(4,183,007)
Balance at Sep. 30, 2019		$ 100	$ 130	$ 165,505	5,462,063	(42,410)	(8,092,081)	(2,377,263)
Balance, shares at Sep. 30, 2019		25,000	129,559	165,504,936
Balance at Jun. 30, 2019		$ 125	$ 130	$ 162,921	5,290,276	(85,723)	(6,968,416)	(1,471,257)
Balance, shares at Jun. 30, 2019	1	125,000	129,559	162,920,724
Debenture conversions				$ 427	45,620			46,047
Debenture conversions, shares				427,500
Exercise of common stock warrants				$ 1,405	116,155			117,560
Exercise of common stock warrants, shares				1,405,000
Issuance of Series B dividend shares				$ 17	1,421			1,438
Issuance of Series B dividend shares, shares				16,794
Conversion of Series B preferred stock		$ (25)		$ 735	(710)
Conversion of Series B preferred stock, shares		(100,000)		734,918
Amortization and revaluation of preferred stock discount					9,301		(9,301)
Dividends on preferred stock							(8,338)	(8,338)
Amortization of deferred compensation						43,313		43,313
Net loss							(1,106,026)	(1,106,026)
Balance at Sep. 30, 2019		$ 100	$ 130	$ 165,505	5,462,063	(42,410)	(8,092,081)	(2,377,263)
Balance, shares at Sep. 30, 2019		25,000	129,559	165,504,936
Balance at Dec. 31, 2019		$ 75	$ 130	$ 169,217	6,035,547		(9,077,614)	(2,872,645)
Balance, shares at Dec. 31, 2019		75,000	129,559	169,217,460
Exercise of stock options				$ 4,000	6,400			10,400
Exercise of stock options, shares				4,000,000
Debenture conversions				$ 2,083	34,212			36,295
Debenture conversions, shares				2,083,333
Exercise of common stock warrants				$ 4,170	121,914			126,084
Exercise of common stock warrants, shares				4,170,000
Issuance of Series B dividend shares				$ 90	3,360			3,450
Issuance of Series B dividend shares, shares				90,216
Conversion of Series B preferred stock		$ (25)		$ 959	(934)
Conversion of Series B preferred stock, shares		(25,000)		958,333
Amortization of preferred stock discount					45,056		(45,056)
Dividends on preferred stock							(6,038)	(6,038)
Common shares issued in connection with notes payable				$ 296	9,704			10,000
Common shares issued in connection with notes payable, shares				294,994
Common shares issued for accrued services				$ 6,662	311,338			318,000
Common shares issued for accrued services, shares				6,662,312
Common shares issued to board of directors				$ 12,942	219,452			232,394
Common shares issued to board of directors, shares				12,942,161
Warrants issued in connection with convertible debenture					41,396			41,396
Common shares issued for services and compensation				$ 16,279	264,352			280,631
Common shares issued for services and compensation, shares				16,279,273
Net loss							(1,762,639)	(1,762,639)
Balance at Sep. 30, 2020		$ 50	$ 130	$ 216,698	7,091,797		(10,891,347)	(3,582,671)
Balance, shares at Sep. 30, 2020		50,000	129,559	216,698,082
Balance at Jun. 30, 2020		$ 50	$ 130	$ 214,615	7,002,953		(10,503,660)	(3,285,912)
Balance, shares at Jun. 30, 2020		50,000	129,559	214,614,749
Debenture conversions				$ 2,083	34,212			36,295
Debenture conversions, shares				2,083,333
Amortization of preferred stock discount					13,236		(13,236)
Dividends on preferred stock							(1,725)	(1,725)
Warrants issued in connection with convertible debenture					41,396			45,068
Net loss							(372,726)	(372,727)
Balance at Sep. 30, 2020		$ 50	$ 130	$ 216,698	$ 7,091,797		$ (10,891,347)	$ (3,582,671)
Balance, shares at Sep. 30, 2020		50,000	129,559	216,698,082

Nature of Business

Nature of Business	9 Months Ended
	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Business	Note 1. Nature of Business Throughout this report, the terms “our,” “we,” “us,” and the “Company” refer to LGBTQ Loyalty Holdings, Inc. (formerly LifeApps Brands Inc.), including its subsidiaries. On January 25, 2019, we acquired LGBT Loyalty LLC, a New York limited liability company, with the goal of creating the first LGBTQ Loyalty Preference Index ETF (the “Index ETF”) to provide the LGBTQ community with the power to influence the allocation of capital within a financial Index ETF based upon LGBTQ consumer preferences. The Index ETF is intended to link the growing economic influence of the LGBTQ community and their allies with many of the top Fortune 500 companies that support and implement diversity, inclusion and equality policies within their organizations. The incorporation of diversity and inclusion in a company’s recruitment and human resource policies is becoming a key concern to investors as part of their growing focus on Environment, Social and Corporate Governance (“ESG”) allocations. Our data and analytics unequivocally reinforce that corporations that have embraced diversity and inclusion policies within their corporate culture perform at a higher level financially than their peers. This includes advancing a more invigorated workforce that attracts and retains the best talent. Innovation and agility have been identified as great benefits of diversity, and there is an increasing awareness of what has come to be known as ‘the power of difference’. On October 30, 2019, through our wholly-owned subsidiary Loyalty Preference Index, Inc. (“LPI”) and our strategically aligned partnerships with crowd sourced data and analytic providers, we launched the LGBTQ100 ESG Index which integrates LGBTQ community survey data into the methodology for a benchmark listing of the nation’s highest financially performing large-cap publicly listed corporations that our respondents believe are most committed to advancing equality. LPI is the index provider for the LGBTQ + ESG100 ETF; LGBTQ Loyalty was the Sponsor for the prospectus that was filed by the licensed Fund Adviser ProcureAM, and was approved by the Securities and Exchange Commission (“SEC”) in early January 2020. The LGBTQ + ESG100 ETF (the “Fund”) seeks to track the investment results (before fees and expenses) of the LGBTQ100 ESG Index. The Fund earns management fees based on assets under management (“AUM”) and is expected to launch in the first quarter of 2021 on the NASDAQ. On June 24, 2020, we formed two wholly-owned subsidiaries, Crowdex Equity Inc. and Advancing Equality Financial Network, Inc.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2. Summary of Significant Accounting Policies Going Concern The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“US GAAP”), which contemplates our continuation as a going concern. We have incurred losses to date of $10,891,347 and have negative working capital of $3,669,204 as of September 30, 2020. To date we have funded our operations through advances from a related party, issuance of convertible debt, and the sale of our common stock. We intend to raise additional funding through third party equity or debt financing. There is no certainty that funding will be available as needed. These factors raise substantial doubt about our ability to continue operating as a going concern. Our ability to continue our operations as a going concern, realize the carrying value of our assets, and discharge our liabilities in the normal course of business is dependent upon our ability to raise capital sufficient to fund our commitments and ongoing losses, and ultimately generate profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Basis of Presentation We have prepared the accompanying condensed consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial reporting. These condensed consolidated financial statements are unaudited and, in our opinion, include all adjustments, consisting of normal recurring adjustments and accruals necessary for a fair presentation of our balance sheets, operating results, and cash flows for the periods presented. Operating results for the periods presented are not necessarily indicative of the results that may be expected for fiscal year 2020. Certain information and footnote disclosures normally included in condensed consolidated financial statements prepared in accordance with US GAAP have been omitted in accordance with the rules and regulations of the SEC. These condensed consolidated financial statements should be read in conjunction with the audited financial statements and accompanying notes. Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of LGBTQ Loyalty Holdings, Inc. and our wholly owned subsidiaries, LGBTQ Loyalty, LLC, LifeApps Inc., Sports One Group Inc., Loyalty Preference Index, Inc, Crowdex Equity Inc. and Advancing Equality Financial Network, Inc. All material inter-company transactions and balances have been eliminated in consolidation. Use of Estimates The preparation of financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the years reported. Actual results may differ from these estimates. Reclassifications The Company has reclassified certain previously reported amounts in its consolidated financial statements. Accordingly, prior year amounts were reclassified to conform to the current year presentation. The reclassifications did not change the previously reported results of operations. Fair Value Measurements ASC Topic 820, Fair Value Measurements and Disclosures (“ASC 820”), provides a comprehensive framework for measuring fair value and expands disclosures which are required about fair value measurements. Specifically, ASC 820 sets forth a definition of fair value and establishes a hierarchy prioritizing the inputs to valuation techniques, giving the highest priority to quoted prices in active markets for identical assets and liabilities and the lowest priority to unobservable value inputs. ASC 820 defines the hierarchy as follows: Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reported date. The types of assets and liabilities included in Level 1 are highly liquid and actively traded instruments with quoted prices, such as equities listed on the New York Stock Exchange. Level 2 – Pricing inputs are other than quoted prices in active markets, but are either directly or indirectly observable as of the reported date. The types of assets and liabilities in Level 2 are typically either comparable to actively traded securities or contracts, or priced with models using highly observable inputs. Level 3 – Significant inputs to pricing that are unobservable as of the reporting date. The types of assets and liabilities included in Level 3 are those with inputs requiring significant management judgment or estimation, such as complex and subjective models and forecasts used to determine the fair value of financial transmission rights and derivative liabilities. Our financial instruments consist of cash, other current assets, accounts payables, accruals, and notes payable. The carrying values of these instruments approximate fair value because of the short-term maturities. The fair value of the Company’s convertible debentures and promissory notes approximates their carrying values as the underlying imputed interest rates approximates the estimated current market rate for similar instruments. The derivative is measured as a Level 3 instrument due to the various inputs which requires significant management judgment. Refer to Note 6 for detail. The following table is a summary of our financial instruments measured at fair value: Fair Value Measurements as of September 30, 2020: Level 1 Level 2 Level 3 Total Liabilities: Derivative liability on convertible notes payable $ - $ - $ 1,291,732 $ 1,291,732 $ - $ - $ 1,291,732 $ 1,291,732 Fair Value Measurements as of December 31, 2019: Level 1 Level 2 Level 3 Total Liabilities: Derivative liability on convertible notes payable $ - $ - $ 1,111,879 $ 1,111,879 $ - $ - $ 1,111,879 $ 1,111,879 Other Receivables – Related Party Other receivables represent amounts held in escrow at the Fund’s custodian. The Company expects to retrieve the funds upon commencement of the Fund’s operations. Earnings per Share We calculate earnings per share in accordance with ASC Topic 260 Earnings Per Share Nine Months Ended September 30, 2020 2019 Stock options outstanding 1,800,000 5,800,000 Warrants 7,500,000 - Shares to be issued upon conversion of notes 260,440,810 17,961,345 269,740,810 23,761,345 Recent Pronouncements Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s consolidated financial statements upon adoption.

Intangible Assets

Intangible Assets	9 Months Ended
	Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Note 3. Intangible Assets During the year ended December 31, 2019, the Company capitalized costs pertaining to the development of the LGBTQ100 ESG Index website. The Company began amortizing upon the launch of the index, and will amortize the costs over a three-year useful life. At September 30, 2020 and December 31, 2019, intangible assets, net was $84,733 and $73,076, respectively. Amortization expense was $6,448 and $19,344, respectively, for the three and nine months ended September 30, 2020.

Notes Payable

Notes Payable	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Notes Payable	Note 4. Notes Payable As of September 30, 2020 and December 31, 2019, the Company has a note payable outstanding in the amount of $3,986 and $7,986, respectively. The note is past due at September 30, 2020 and is therefore in default. The note accrues interest at a rate of 2% per annum. In January 2020, the Company issued a note payable to a lender for a principal amount of $50,000. The Company received proceeds of $47,500 and the note matured on February 5, 2020. As of September 30, 2020, the note is past due and in default. As of September 30, 2020 and December 31, 2019, the outstanding balance was $50,000. In December 2019, the Company issued a promissory note to Pride Partners LLC (“Pride”) for $75,000. The note is secured, accrues interest at a rate of 10% per annum, and matures on June 20, 2020. As of September 30, 2020, the note is past due and in default. As of September 30, 2020 and December 31, 2019, the outstanding balance was $75,000.

Convertible Notes Payable

Convertible Notes Payable	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Convertible Notes Payable	Note 5. Convertible Notes Payable Convertible Note In February 2019, the holder of a March 2018 convertible promissory note in the original principal amount of $35,000 converted $26,920 in principal and $4,255 in interest into an aggregate of 26,398,704 shares of our common stock at a conversion price of $0.0015 per share. As the result of such conversions, this note has been repaid in full and terminated. Convertible Debenture On February 12, 2020, the Company entered into a Securities Purchase Agreement with Cavalry Fund I LP (the “Calvary Note”). Pursuant to the terms of the Calvary Note, the lender agreed to purchase from the Company, for a purchase price of $100,000, a 10% convertible note in the principal amount of $115,500. The Cavalry Note matures and becomes due and payable on November 11, 2020 and accrues interest at a rate of 10% per annum. The Calvary Note, plus all accrued but unpaid interest, may be prepaid at any time prior to the maturity date. The Calvary Note is convertible into shares of the Company’s common stock at any time at a conversion price (the “Conversion Price”) equal to the lower of: (i) the lowest closing price of the common stock during the preceding twenty (20) trading day period ending on the latest complete trading day prior to the issuance date of the Note (the “Closing Price”), (ii) $0.04, or (iii) 60% of the lowest traded price for the Common Stock on the principal market on which the Common Stock is then trading during the twenty (20) consecutive trading days on which at least 100 shares of Common Stock were traded including and immediately preceding the date of conversion. Upon an event of default, the holder may elect to convert at an alternate conversion price which is the lower of: (i) the closing price of the Common Stock on the Principal Market on the Trading Day immediately preceding the issue date of the Calvary Note or (ii) 60% of either the lowest traded price or the closing bid price, whichever is lower for the common stock on the principal market during any trading day in which the event of default has not been cured. The conversion price of the Note will be further adjusted by another 15% reduction, regardless of whether there is an event of default, if (A) the Common stock is no longer a reporting company pursuant to the Securities Exchange Act of 1934, as amended, (B) the Note cannot be converted into free trading shares after 181 days from the issuance date of the Note, (C) the Common Stock is chilled for deposit at DTC or becomes chilled at any point while the Note remains outstanding, (D) deposit or other additional fees are payable due to a Yield Sign, Stop Sign or other trading restrictions, or (E) if the closing price at any time falls below $0.015. The conversion price is subject to customary adjustments. The conversion price is not subject to a floor. Effective July 14, 2020, the Company and Calvary Fund I LP entered into an amendment to the Calvary Note to extend the maturity date of the note from November 11, 2020 to December 31, 2020, prohibit any conversions of the note prior to October 31, 2020, and extend the prepayment option from August 9, 2020 to December 31, 2020. On March 10, 2020, the Company entered into a Securities Purchase Agreement with Power Up Lending Group Ltd (“Power Up Note”). Pursuant to the terms of the Power Up Note, the lender agreed to purchase from the Company, for a purchase price of $75,000, a 10% convertible note in the principal amount of $85,800. The Power Up Note matures and becomes due and payable on March 10, 2021 and accrues interest at a rate of 10% per annum. The Power Up Note, plus all accrued but unpaid interest, may be prepaid at any time prior to the maturity date. The Power Up Note is convertible into shares of the Company’s common stock at any time at a conversion price (the “Conversion Price”), which shall equal the Variable Conversion Price. The “Variable Conversion Price” shall mean 60% multiplied by the Market Price, which is the lowest Trading Price for the common stock during the twenty (20) trading day period ending on the latest complete trading day prior to the conversion date. The conversion price is subject to customary adjustments. The conversion price is not subject to a floor. As of September 30, 2020, the noteholder had converted $15,000 in principal for 2,083,333 shares of common stock. On May 26, 2020, the Company entered into a Securities Purchase Agreement with Power Up Lending Group Ltd (“Power Up May Note”). Pursuant to the terms of the Power Up May Note, the lender agreed to purchase from the Company, for a purchase price of $75,000, a 10% convertible note in the principal amount of $85,800. The Power Up May Note matures and becomes due and payable on May 26, 2021 and accrues interest at a rate of 10% per annum. The Power Up Note, plus all accrued but unpaid interest, may be prepaid at any time prior to the maturity date. The Power Up May Note is convertible into shares of the Company’s common stock at any time at a conversion price (the “Conversion Price”), which shall equal the Variable Conversion Price. The “Variable Conversion Price” shall mean 60% multiplied by the Market Price, which is the lowest Trading Price for the common stock during the twenty (20) trading day period ending on the latest complete trading day prior to the conversion date. The conversion price is subject to customary adjustments. The conversion price is not subject to a floor. On August 11, 2020, the Company entered into a Securities Purchase Agreement (the “SPA”) with Auctus Fund, LLC (“Auctus”). Pursuant to the terms of the SPA, the Purchaser agreed to purchase from the Company, for a purchase price of $132,000, a 12% Convertible Note in the principal amount of $150,000. The Note matures and becomes due and payable on August 11, 2021 and accrues interest at a rate of 12% per annum while the Note remains outstanding. The Note may be prepaid on a monthly basis commencing six months after closing. The Note is convertible into shares of the Company’s common stock at any time at a conversion price (“Conversion Price”) equal to the lesser of (i) Current Market Price and (ii) the Variable Conversion Price. The Variable Conversion Price shall mean 100% multiplied by the Market Price (representing a discount rate of 0%). Market Price means the average of the previous 5 days volume weighted average price. In connection with the Note, the Company issued two common stock purchase warrants to purchase up to an aggregate of 15,000,000 shares of common stock (separately, “Warrant A” and “Warrant B”, and together, the “Warrants” and each a “Warrant”), upon the terms and subject to the limitations and conditions set forth in the Note. As of September 30, 2020, one warrant to purchase 7,500,000 shares was issued and outstanding to Auctus. The fair value of the warrants was determined to be $45,068 and was recorded as a debt discount to the note. On September 28, 2020, the Company entered into a convertible promissory note (“JSJ Note”) with JSJ Investments, Inc., pursuant to which JSJ purchased from the Company, at a purchase price of $100,000, a 10% Convertible Note in the principal amount of $108,000. The JSJ Note accrues interest at a rate of 10% per annum and matures on September 28, 2021. The JSJ Note, plus all accrued but unpaid interest and other amounts due on the JSJ Note, may be prepaid at any time prior to the maturity date. Upon an event of default, the interest rate shall increase to 18% for as long as the event of default is continuing (“Default Interest”). At any time on or after the Maturity Date, the Company may repay the then outstanding principal plus accrued interest and Default Interest, if any, to JSJ. The JSJ Note is convertible into shares of the Company’s common stock at any time after 180 days from the issuance date. The conversion price is 60% multiplied by the lowest trading price for the common stock during the 20 trading day period ending on the latest complete trading day prior to the date of a conversion notice. On September 29, 2020, the Company entered into a Securities Purchase Agreement with Power Up Lending Group Ltd (“Power Up September Note”). Pursuant to the terms of the Power Up September Note, the lender agreed to purchase from the Company, for a purchase price of $80,000, a 10% convertible note in the principal amount of $91,300. The Power Up September Note matures and becomes due and payable on September 29, 2021 and accrues interest at a rate of 10% per annum. The Power Up September Note, plus all accrued but unpaid interest, may be prepaid at any time prior to the maturity date. The Power Up September Note is convertible into shares of the Company’s common stock at any time at a conversion price (the “Conversion Price”), which shall equal the Variable Conversion Price. The “Variable Conversion Price” shall mean 60% multiplied by the Market Price, which is the lowest Trading Price for the common stock during the twenty (20) trading day period ending on the latest complete trading day prior to the conversion date. The conversion price is subject to customary adjustments. The conversion price is not subject to a floor. On March 11, 2020, the Company entered into a Securities Purchase Agreement (the “EMA Note”) with EMA Financial, LLC. Pursuant to the terms of the EMA Note, EMA agreed to purchase from the Company, for a purchase price of $75,000, a 10% Convertible Note in the principal amount of $85,000. The EMA Note accrues interest at a rate of 10% per annum and matures on November 5, 2020. The EMA Note, plus all accrued but unpaid interest and other amounts due on the EMA Note, may be prepaid at any time prior to the maturity date. The EMA Note is convertible into shares of the Company’s common stock. The conversion price shall be the lower of: (i) the lowest closing price of the common stock during the preceding 20 trading day period ending on the latest complete trading day prior to March 11, 2020, (ii) $0.04, or (iii) 60% of the lowest traded price for the common stock on the principal market during the 20 consecutive trading days on which at least 100 shares of common stock were traded including and immediately preceding the conversion date. Additional discounts to the conversion price and penalties will apply if certain events occur, including if the closing price drops below $0.015, if the Company’s stock is subject to a DTC chill, or if the EMA Note cannot be converted in free trading shares after 181 days from the issuance date. Effective as of September 29, 2020, the Company and EMA entered into an Amendment to the Note (the “EMA Amendment”), pursuant to which EMA and the Company agreed to amend the issuance date of the EMA Note from March 11, 2020 to September 29, 2020 and to extend the maturity date of the EMA Note from November 5, 2020 to September 29, 2021. During the three and nine months ended September 30, 2020, the Company recorded amortization of debt discount and original discount of $181,681 and $584,445, respectively, for all convertible debentures. This amount is included in interest expense in our consolidated statements of operations. The following is a summary of the activity of the convertible notes payable and convertible debenture for the nine months ended September 30, 2020: Total Balance as of December 31, 2019 $ 363,769 Issuance of convertible debenture - principal amount 721,400 Issuance of convertible debenture - debt discount and original issue discount (725,235 ) Amortization of debt discount and original issue discount 584,445 Balance as of September 30, 2020 $ 944,379 The following comprises the balance of the convertible debenture outstanding at September 30, 2020 and December 31, 2019: September 30, December 31, 2020 2019 Principal amount outstanding $ 1,784,490 $ 1,078,090 Less: Unamortized original issue discount (53,118 ) (62,779 ) Less: Unamortized debt discount (786,993 ) (651,542 ) $ 944,379 $ 363,769

Derivative Liability

Derivative Liability	9 Months Ended
	Sep. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liability	Note 6. Derivative Liability We evaluated the terms of the conversion features of the debentures in accordance with ASC Topic No. 815 - 40, Derivatives and Hedging - Contracts in Entity’s Own Stock To determine the fair value of our embedded derivatives, management evaluates assumptions regarding the probability of certain future events. Other factors used to determine fair value include our period end stock price, historical stock volatility, risk free interest rate and derivative term. The fair value recorded for the derivative liability varies from period to period. This variability may result in the actual derivative liability for a period either above or below the estimates recorded on our consolidated financial statements, resulting in significant fluctuations in other income (expense) because of the corresponding non-cash gain or loss recorded. We value the conversion feature at origination of the notes using the Black-Scholes valuation model. We value the derivative liability at the end of each accounting period, and upon conversion of the underlying note or warrant, with the difference in value recognized as gain or loss included in other income (expense) in our consolidated statements of operations. The original debentures had conversion features that resulted in derivative liabilities. We valued the conversion features at each origination date with the following assumptions, on a weighted-average basis: Nine Months Ended September 30, 2020 Risk-free interest rate 0.39 % Expected term (in years) 0.96 Expected volatility 191.1 % Expected dividend yield 0 % Exercise price of underlying common shares $ 0.01 Year Ended December 31, 2019 Tranche 1 Tranche 2 Tranche 3 Warrants Risk-free interest rate 2.11 % 1.75 % 1.67 % 2.11 % Expected term (in years) 1.25 1.03 0.89 1.25 Expected volatility 312.4 % 303.70 % 326.88 % 312.4 % Expected dividend yield 0 % 0 % 0 % 0 % Exercise price of underlying common shares $ 0.09 $ 0.04 $ 0.04 $ 0.08 During the nine months ended September 30, 2020, the entire value of the principal of the debentures were assigned to the derivative liability and recognized as a debt discount on the convertible debentures. The debt discount is recorded as reduction (contra-liability) to the debentures and are being amortized over the initial term. The balance of $440,182 was recognized as origination interest on the derivative liability and expensed on origination. The following is a summary of the activity of the derivative liability for the nine months ended September 30, 2020: Debenture Warrants Total Balance as of December 31, 2019 $ 1,047,977 $ 63,902 $ 1,111,879 Initial fair value on issuance of convertible debenture 1,039,620 - 1,039,620 Debenture conversions (21,296 ) - (21,296 ) New warrant issuances - 39,690 39,690 Common stock warrant exercises - (72,244 ) (72,244 ) Change in fair value of derivative liability (774,569 ) (31,348 ) (805,917 ) Balance as of September 30, 2020 $ 1,291,732 $ - $ 1,291,732

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit)	9 Months Ended
	Sep. 30, 2020
Equity [Abstract]
Stockholders' Equity (Deficit)	Note 7. Stockholders’ Equity (Deficit) Common Stock 2020 Transactions In January 2020, we issued 294,994 shares of common stock to a bridge noteholder in connection with promissory notes received. During the nine months ended September 30, 2020, we issued an aggregate of 10,052,318 shares of common stock to consultants for 2019 services which were accrued at a fair value of $459,417. In March 2020, we issued 1,000,000 shares to Orlando Reece pursuant to his appointment to the Board of Directors. In May 2020, we issued an aggregate of 11,942,161 shares to directors as compensation. In April 2020, we issued 90,216 shares and 958,333 shares of common stock to a Series B Preferred Stock investor for accrued dividends and conversion of 25,000 shares of the Series B Preferred Stock. In May 2020, we issued an aggregate of 12,889,267 shares of common stock to executives, officers and consultants for services rendered for a total fair value of $139,215. In June 2020, two option holders exercised their outstanding options for a total of 4,000,000 shares of common stock at an exercise price of $0.0026. The value of $10,400 was converted from outstanding accounts payable. During the nine months ended September 30, 2020, we issued an aggregate of 4,170,000 shares of common stock to Pride Partners pursuant to warrant exercises. Refer to Note 8. In September 2020, the Company issued 2,083,333 shares of common stock pursuant to conversion of a debenture in the principal amount of $15,000. 2019 Transactions In January 2019, we entered into and closed a securities exchange under a Securities Exchange Agreement (the “Securities Exchange Agreement”) with LGBT Loyalty LLC (“LGBT Loyalty”) and Maxim Partners, LLC (“Maxim”), pursuant to which we acquired all of the membership interests of LGBT Loyalty, making LGBT Loyalty a wholly owned subsidiary of ours, in exchange for 120,959,996 shares (the “Shares”) of our restricted common stock and one share of our newly created Series A Convertible Preferred Stock (the “Series A Preferred Stock”). The Shares issued to Maxim represented, upon issuance, 49.99% of our then issued and outstanding shares of common stock. On March 29, 2019 an additional 8,598,578 shares were issued to Maxim for the conversion of the Series A Convertible Preferred Stock. LGBT Loyalty has no assets, liabilities nor operations at the exchange date, therefore, the value ascribed to the issued stock ($388,675) has been charged to operations as expenses of the merger. On June 4, 2019 we entered into a Securities Exchange Agreement with Maxim pursuant to which the Maxim exchanged 129,558,574 shares of common stock for 129,559 shares of our Series C Preferred Stock. In February 2019, we issued an aggregate of 750,000 shares of common stock to a consultant in accordance with a service contract that provided for a 250,000 share stock grant for services performed of $7,500, as well as the exercise of 500,000 stock options in exchange for the cancellation of $5,000 then outstanding accounts payable due to the consultant for prior services. In March 2019, we issued an aggregate of 8,600,298 shares of our common stock pursuant to the automatic exercise of warrants issued to two current and prior company officers. In March and April 2019, we issued an aggregate of 5,000,000 shares of common stock to five unrelated individuals in accordance with their appointment as directors of the Company. During the nine months ended September 30, 2019, we issued 26,586,204 shares of our common stock to a lender pursuant to note conversions. During the nine months ended September 30, 2019, we issued 427,500 shares and 1,405,000 shares to Pride pursuant to debenture conversions and exercise of common stock warrants. Series B Convertible Preferred Stock As of September 30, 2020, we had $10,350 in remaining accrued Series B dividends.

Options and Warrants

Options and Warrants	9 Months Ended
	Sep. 30, 2020
Share-based Payment Arrangement [Abstract]
Options and Warrants	Note 8. Options and Warrants Options As of September 30, 2020 and December 31, 2019, we had 1,800,000 and 5,800,000 options, respectively, remaining outstanding pursuant to the 2012 Equity Incentive Plan. There was no stock based compensation expense for options for the nine months ended September 30, 2020 and 2019. There will be no additional compensation expense recognized in future periods. Warrants During the nine months ended September 30, 2020, Pride exercised an aggregate of 4,170,000 shares of common stock pursuant to the exercise provisions of the warrant, including a simultaneous grant and exercise of 2,285,000 warrants. As of September 30, 2020, Pride had no outstanding warrants remaining. The Company received total proceeds of $93,342 a result of the warrant exercises. In May 2020, we cancelled warrants that were issued in 2019 to board members to purchase an aggregate of 7,000,000 shares of our common stock. See Note 9. In August 2020, we issued 7,500,000 shares to Auctus in connection with the Auctus Note. The exercise price of the Auctus Warrants is $0.15 per share. On January 25, 2019 we issued warrants to two Company executives in exchange for the cancellation of an aggregate of $348,312 of salary and interest accruals through December 31, 2018. The warrants were fully exercised as described in Note 7 above. The following is a summary of the warrant activity for the nine months ended September 30, 2020: Warrants Weighted Average Exercise Price Outstanding as of December 31, 2019 8,885,000 $ 0.04 Granted 9,785,000 0.03 Exercised (4,170,000 ) 0.08 Forfeited (7,000,000 ) 0.03 Outstanding as of September 30, 2020 7,500,000 $ 0.02

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2020
Related Party Transactions [Abstract]
Related Party Transactions	Note 9. Related Party Transactions Parties, which can be a corporation or an individual, are considered to be related if we have the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence. Notes Payable to Related Party During the quarter ended September 30, 2020, the Company received proceeds of $48,675 pursuant to short-term promissory notes with related parties. Currently the Company has defaulted on all of their related party loan obligations. Forbearance has been granted by the related parties on all loans. Accrued Salaries In March 2019, we issued an aggregate of 8,600,298 shares of our common stock pursuant to the automatic exercise of warrants issued to two current and prior company officers. The warrants were issued in exchange for the cancellation of an aggregate of $348,312 of salary and interest accruals through December 31, 2018. As of September 30, 2020 and December 31, 2019, accrued salaries to our company officers and executive director totaled $ 193,552 and $91,352, respectively, and is included in accrued salaries and consulting fees in our consolidated balance sheets. Board of Directors In March 2020, the Company issued 1,000,000 shares to Orlando Reece pursuant to his appointment to the board, and recognized $17,800 in compensation expense. In May 2020, we issued an aggregate of 11,942,161 shares to directors as compensation, including 3,942,161 shares pursuant to accrued monthly fees and 8,000,000 shares pursuant to 2020 annual compensation. In conjunction with this transaction, we cancelled 7,000,000 warrants that were issued to the board in December 2019. We accounted for the modification in accordance with ASC 718-20-35. Total fair value of the shares issued and warrant modification was $214,595. In March and April 2019, we issued an aggregate of 5,000,000 shares of common stock to five unrelated individuals in accordance with their appointment as directors of the Company, and recognized $555,401 in compensation expense. Total accrued directors’ compensation of $50,834 and $80,000 at September 30, 2020 and December 31, 2019, respectively, is included in accrued salaries and consulting fees on our consolidated balance sheets. A board member is the co-founder and president of ProcureAM, LLC, the fund advisor for the Fund. As of September 30, 2020 and December 31, 2019, we have $100,000 included as other receivables on our consolidated balance sheet, which represents amounts held in escrow at the Fund’s custodian.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2020
Subsequent Events [Abstract]
Subsequent Events	Note 10. Subsequent Events Management has evaluated all activity up to November 16, 2020 and concluded that no subsequent events have occurred that would require recognition in these financial statements or disclosure in the notes to these financial statements other than the following: In October 2020, the Company issued 16,718,951 shares of common stock pursuant to conversion of a debenture in the principal amount of $74,700. On October 8, 2020, the Company entered into a Securities Purchase Agreement (the “Auctus October Note”) with Auctus Fund, Pursuant to the terms of the Auctus October Note, Auctus agreed to purchase from the Company, for a purchase price of $300,000: (i) a Convertible Promissory Note in the principal amount of $300,000 (the “Auctus Note”); (ii) a common stock purchase warrant permitting Auctus to purchase up to 100,000,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at an exercise price of $0.015 per share (the “Warrant A”); and (iii) a common stock purchase warrant permitting Auctus to purchase up to 100,000,000 shares of the Company’s Common Stock at an exercise price of $0.015 per share (the “Warrant B”) and together with the Warrant A, the “Warrants”). The Auctus October Note accrues interest at a rate of 12% per annum and matures on October 8, 2021. The Auctus October Note is convertible into shares of the Company’s Common Stock, subject to the adjustments described therein. The conversion price shall be the “Market Price” which is defined as the volume weighted average price for the Common Stock during the 5 trading day period ending on the latest complete trading day prior to the conversion date.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Going Concern	Going Concern The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“US GAAP”), which contemplates our continuation as a going concern. We have incurred losses to date of $10,891,347 and have negative working capital of $3,669,204 as of September 30, 2020. To date we have funded our operations through advances from a related party, issuance of convertible debt, and the sale of our common stock. We intend to raise additional funding through third party equity or debt financing. There is no certainty that funding will be available as needed. These factors raise substantial doubt about our ability to continue operating as a going concern. Our ability to continue our operations as a going concern, realize the carrying value of our assets, and discharge our liabilities in the normal course of business is dependent upon our ability to raise capital sufficient to fund our commitments and ongoing losses, and ultimately generate profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
Basis of Presentation	Basis of Presentation We have prepared the accompanying condensed consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial reporting. These condensed consolidated financial statements are unaudited and, in our opinion, include all adjustments, consisting of normal recurring adjustments and accruals necessary for a fair presentation of our balance sheets, operating results, and cash flows for the periods presented. Operating results for the periods presented are not necessarily indicative of the results that may be expected for fiscal year 2020. Certain information and footnote disclosures normally included in condensed consolidated financial statements prepared in accordance with US GAAP have been omitted in accordance with the rules and regulations of the SEC. These condensed consolidated financial statements should be read in conjunction with the audited financial statements and accompanying notes.
Principles of Consolidation	Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of LGBTQ Loyalty Holdings, Inc. and our wholly owned subsidiaries, LGBTQ Loyalty, LLC, LifeApps Inc., Sports One Group Inc., Loyalty Preference Index, Inc, Crowdex Equity Inc. and Advancing Equality Financial Network, Inc. All material inter-company transactions and balances have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the years reported. Actual results may differ from these estimates.
Reclassifications	Reclassifications The Company has reclassified certain previously reported amounts in its consolidated financial statements. Accordingly, prior year amounts were reclassified to conform to the current year presentation. The reclassifications did not change the previously reported results of operations.
Fair Value Measurements	Fair Value Measurements ASC Topic 820, Fair Value Measurements and Disclosures (“ASC 820”), provides a comprehensive framework for measuring fair value and expands disclosures which are required about fair value measurements. Specifically, ASC 820 sets forth a definition of fair value and establishes a hierarchy prioritizing the inputs to valuation techniques, giving the highest priority to quoted prices in active markets for identical assets and liabilities and the lowest priority to unobservable value inputs. ASC 820 defines the hierarchy as follows: Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reported date. The types of assets and liabilities included in Level 1 are highly liquid and actively traded instruments with quoted prices, such as equities listed on the New York Stock Exchange. Level 2 – Pricing inputs are other than quoted prices in active markets, but are either directly or indirectly observable as of the reported date. The types of assets and liabilities in Level 2 are typically either comparable to actively traded securities or contracts, or priced with models using highly observable inputs. Level 3 – Significant inputs to pricing that are unobservable as of the reporting date. The types of assets and liabilities included in Level 3 are those with inputs requiring significant management judgment or estimation, such as complex and subjective models and forecasts used to determine the fair value of financial transmission rights and derivative liabilities. Our financial instruments consist of cash, other current assets, accounts payables, accruals, and notes payable. The carrying values of these instruments approximate fair value because of the short-term maturities. The fair value of the Company’s convertible debentures and promissory notes approximates their carrying values as the underlying imputed interest rates approximates the estimated current market rate for similar instruments. The derivative is measured as a Level 3 instrument due to the various inputs which requires significant management judgment. Refer to Note 6 for detail. The following table is a summary of our financial instruments measured at fair value: Fair Value Measurements as of September 30, 2020: Level 1 Level 2 Level 3 Total Liabilities: Derivative liability on convertible notes payable $ - $ - $ 1,291,732 $ 1,291,732 $ - $ - $ 1,291,732 $ 1,291,732 Fair Value Measurements as of December 31, 2019: Level 1 Level 2 Level 3 Total Liabilities: Derivative liability on convertible notes payable $ - $ - $ 1,111,879 $ 1,111,879 $ - $ - $ 1,111,879 $ 1,111,879
Other Receivables - Related Party	Other Receivables – Related Party Other receivables represent amounts held in escrow at the Fund’s custodian. The Company expects to retrieve the funds upon commencement of the Fund’s operations.
Earnings Per Share	Earnings per Share We calculate earnings per share in accordance with ASC Topic 260 Earnings Per Share Nine Months Ended September 30, 2020 2019 Stock options outstanding 1,800,000 5,800,000 Warrants 7,500,000 - Shares to be issued upon conversion of notes 260,440,810 17,961,345 269,740,810 23,761,345
Recent Pronouncements	Recent Pronouncements Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s consolidated financial statements upon adoption.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Schedule of Financial Instruments at Fair Value	The following table is a summary of our financial instruments measured at fair value: Fair Value Measurements as of September 30, 2020: Level 1 Level 2 Level 3 Total Liabilities: Derivative liability on convertible notes payable $ - $ - $ 1,291,732 $ 1,291,732 $ - $ - $ 1,291,732 $ 1,291,732 Fair Value Measurements as of December 31, 2019: Level 1 Level 2 Level 3 Total Liabilities: Derivative liability on convertible notes payable $ - $ - $ 1,111,879 $ 1,111,879 $ - $ - $ 1,111,879 $ 1,111,879
Schedule of Antidilutive Securities Excluded from Diluted Net Loss	For the three and nine months ended September 30, 2020 and 2019, the following number of potentially dilutive shares have been excluded from diluted net loss since such inclusion would be anti-dilutive: Nine Months Ended September 30, 2020 2019 Stock options outstanding 1,800,000 5,800,000 Warrants 7,500,000 - Shares to be issued upon conversion of notes 260,440,810 17,961,345 269,740,810 23,761,345

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Summary of Activity of Convertible Notes Payable and Convertible Debenture	The following is a summary of the activity of the convertible notes payable and convertible debenture for the nine months ended September 30, 2020: Total Balance as of December 31, 2019 $ 363,769 Issuance of convertible debenture - principal amount 721,400 Issuance of convertible debenture - debt discount and original issue discount (725,235 ) Amortization of debt discount and original issue discount 584,445 Balance as of September 30, 2020 $ 944,379
Schedule of Balance Convertible Debenture Outstanding	The following comprises the balance of the convertible debenture outstanding at September 30, 2020 and December 31, 2019: September 30, December 31, 2020 2019 Principal amount outstanding $ 1,784,490 $ 1,078,090 Less: Unamortized original issue discount (53,118 ) (62,779 ) Less: Unamortized debt discount (786,993 ) (651,542 ) $ 944,379 $ 363,769

Derivative Liability (Tables)

Derivative Liability (Tables)	9 Months Ended
	Sep. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Conversion Feature of Derivative Liability	The original debentures had conversion features that resulted in derivative liabilities. We valued the conversion features at each origination date with the following assumptions, on a weighted-average basis: Nine Months Ended September 30, 2020 Risk-free interest rate 0.39 % Expected term (in years) 0.96 Expected volatility 191.1 % Expected dividend yield 0 % Exercise price of underlying common shares $ 0.01 Year Ended December 31, 2019 Tranche 1 Tranche 2 Tranche 3 Warrants Risk-free interest rate 2.11 % 1.75 % 1.67 % 2.11 % Expected term (in years) 1.25 1.03 0.89 1.25 Expected volatility 312.4 % 303.70 % 326.88 % 312.4 % Expected dividend yield 0 % 0 % 0 % 0 % Exercise price of underlying common shares $ 0.09 $ 0.04 $ 0.04 $ 0.08
Schedule of Derivative Liability Activity	The following is a summary of the activity of the derivative liability for the nine months ended September 30, 2020: Debenture Warrants Total Balance as of December 31, 2019 $ 1,047,977 $ 63,902 $ 1,111,879 Initial fair value on issuance of convertible debenture 1,039,620 - 1,039,620 Debenture conversions (21,296 ) - (21,296 ) New warrant issuances - 39,690 39,690 Common stock warrant exercises - (72,244 ) (72,244 ) Change in fair value of derivative liability (774,569 ) (31,348 ) (805,917 ) Balance as of September 30, 2020 $ 1,291,732 $ - $ 1,291,732

Options and Warrants (Tables)

Options and Warrants (Tables)	9 Months Ended
	Sep. 30, 2020
Share-based Payment Arrangement [Abstract]
Summary of Warrant Activity	The following is a summary of the warrant activity for the nine months ended September 30, 2020: Warrants Weighted Average Exercise Price Outstanding as of December 31, 2019 8,885,000 $ 0.04 Granted 9,785,000 0.03 Exercised (4,170,000 ) 0.08 Forfeited (7,000,000 ) 0.03 Outstanding as of September 30, 2020 7,500,000 $ 0.02

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details Narrative)	9 Months Ended
	Sep. 30, 2020USD ($)
Accounting Policies [Abstract]
Incurred losses	$ 10,891,347
Working capital	$ 3,669,204

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Schedule of Financial Instruments at Fair Value (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Derivative liability on convertible notes payable	$ 1,291,732	$ 1,111,879
Derivative instruments at fair value	1,291,732	1,111,879
Level 1 [Member]
Derivative liability on convertible notes payable
Derivative instruments at fair value
Level 2 [Member]
Derivative liability on convertible notes payable
Derivative instruments at fair value
Level 3 [Member]
Derivative liability on convertible notes payable	1,291,732	1,111,879
Derivative instruments at fair value	$ 1,291,732	$ 1,111,879

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Diluted Net Loss (Details) - shares	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Antidilutive securities excluded from computation of earnings per share, amount	269,740,810	23,761,345
Stock Options Outstanding [Member]
Antidilutive securities excluded from computation of earnings per share, amount	1,800,000	5,800,000
Warrants [Member]
Antidilutive securities excluded from computation of earnings per share, amount	7,500,000
Shares to be Issued Upon Conversion of Notes [Member]
Antidilutive securities excluded from computation of earnings per share, amount	260,440,810	17,961,345

Intangible Assets (Details Narr

Intangible Assets (Details Narrative) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible assets, net	$ 84,733	$ 84,733	$ 73,076
Amortization expense	$ 6,448	$ 19,344

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019	Jan. 31, 2020
Debt principal amount	$ 1,784,490	$ 1,078,090
Note Payable [Member]
Note payable outstanding	$ 3,986	$ 7,986
Debt instrument interest rate	2.00%	2.00%
Note Payable [Member] | Lender [Member]
Debt principal amount			$ 50,000
Proceeds from issuance of debt	$ 47,500
Debt maturity date	Feb. 5, 2020
Note Payable [Member]
Note payable outstanding	$ 50,000	$ 50,000
Promissory Note [Member] | Pride Partners LLC [Member]
Note payable outstanding		$ 75,000
Debt instrument interest rate		10.00%
Debt maturity date		Jun. 20, 2020
Note Payable [Member]
Note payable outstanding	$ 75,000	$ 75,000

Convertible Notes Payable (Deta

Convertible Notes Payable (Details Narrative)	Sep. 29, 2020USD ($)Trading	Sep. 28, 2020USD ($)Trading	Aug. 11, 2020USD ($)shares	May 26, 2020USD ($)Trading	Mar. 11, 2020USD ($)Trading$ / sharesshares	Mar. 10, 2020USD ($)Trading	Feb. 12, 2020USD ($)Trading$ / sharesshares	Sep. 30, 2020USD ($)shares	Mar. 31, 2019shares	Feb. 28, 2019USD ($)$ / sharesshares	Sep. 30, 2020USD ($)shares	Sep. 30, 2019USD ($)	Sep. 30, 2020USD ($)shares	Sep. 30, 2019USD ($)shares	Dec. 31, 2019USD ($)
Convertible notes payable								$ 944,379			$ 944,379		$ 944,379		$ 363,769
Debt principal amount								1,784,490			1,784,490		1,784,490		$ 1,078,090
Stock issued during the period convertible								$ 15,000			36,295	$ 46,047	36,295	$ 46,047
Stock issued during the period convertible, shares | shares								2,083,333						427,500
Number of shares of common stock | shares									8,600,298
Amortization of debt discount and original discount											$ 181,681		584,445	$ 124,660
Noteholder [Member]
Stock issued during the period convertible													$ 15,000
Stock issued during the period convertible, shares | shares													2,083,333
Securities Purchase Agreement [Member] | Cavalry Fund I LP [Member]
Debt principal amount							$ 115,500
Purchase price							$ 100,000
Debt interest rate							10.00%
Debt maturity date							Nov. 11, 2020
Trading days | Trading							20
Debt description							The lowest closing price of the common stock during the preceding twenty (20) trading day period ending on the latest complete trading day prior to the issuance date of the Note (the "Closing Price"), (ii) $0.04, or (iii) 60% of the lowest traded price for the Common Stock on the principal market on which the Common Stock is then trading during the twenty (20) consecutive trading days on which at least 100 shares of Common Stock were traded including and immediately preceding the date of conversion. Upon an event of default, the holder may elect to convert at an alternate conversion price which is the lower of: (i) the closing price of the Common Stock on the Principal Market on the Trading Day immediately preceding the issue date of the Calvary Note or (ii) 60% of either the lowest traded price or the closing bid price, whichever is lower for the common stock on the principal market during any trading day in which the event of default has not been cured. The conversion price of the Note will be further adjusted by another 15% reduction, regardless of whether there is an event of default
Consecutive trading days | Trading							20
Number of shares of common stock | shares							100
Reduction percentage							15.00%
Closing price | $ / shares							$ 0.015
Securities Purchase Agreement [Member] | Power Up Lending Group Ltd [Member]
Debt principal amount	$ 91,300			$ 85,800		$ 85,800
Purchase price	$ 80,000			$ 75,000		$ 75,000
Debt interest rate	10.00%			10.00%		10.00%
Debt maturity date	Sep. 29, 2021			May 26, 2021		Mar. 10, 2021
Trading days | Trading	20			20		20
Debt description	The "Variable Conversion Price" shall mean 60% multiplied by the Market Price, which is the lowest Trading Price for the common stock during the twenty (20) trading day period ending on the latest complete trading day prior to the conversion date. The conversion price is subject to customary adjustments. The conversion price is not subject to a floor.			The "Variable Conversion Price" shall mean 60% multiplied by the Market Price, which is the lowest Trading Price for the common stock during the twenty (20) trading day period ending on the latest complete trading day prior to the conversion date.		The "Variable Conversion Price" shall mean 60% multiplied by the Market Price, which is the lowest Trading Price for the common stock during the twenty (20) trading day period ending on the latest complete trading day prior to the conversion date.
Securities Purchase Agreement [Member] | Auctus Fund LLC [Member]
Debt principal amount			$ 150,000
Debt converted into shares | shares			15,000,000
Purchase price			$ 132,000
Debt interest rate			12.00%
Debt maturity date			Aug. 11, 2021
Debt description			The Variable Conversion Price shall mean 100% multiplied by the Market Price (representing a discount rate of 0%). Market Price means the average of the previous 5 days volume weighted average price. In connection with the Note, the Company issued two common stock purchase warrants to purchase up to an aggregate of 15,000,000 shares of common stock (separately
Warrants to purchase | shares								7,500,000			7,500,000		7,500,000
Fair value of warrants													$ 45,068
Securities Purchase Agreement [Member] | EMA Financial, LLC [Member]
Debt principal amount					$ 85,000
Purchase price					$ 75,000
Debt interest rate					10.00%
Debt maturity date					Nov. 5, 2020
Trading days | Trading					20
Debt description					The conversion price shall be the lower of: (i) the lowest closing price of the common stock during the preceding 20 trading day period ending on the latest complete trading day prior to March 11, 2020, (ii) $0.04, or (iii) 60% of the lowest traded price for the common stock on the principal market during the 20 consecutive trading days on which at least 100 shares of common stock were traded including and immediately preceding the conversion date. Additional discounts to the conversion price and penalties will apply if certain events occur, including if the closing price drops below $0.015, if the Company's stock is subject to a DTC chill, or if the EMA Note cannot be converted in free trading shares after 181 days from the issuance date.
Consecutive trading days | Trading					20
Number of shares of common stock | shares					100
Closing price | $ / shares					$ 0.015
Conversion price					0.60
2018 Convertible Promissory Note [Member]
Convertible notes payable										$ 35,000
Debt principal amount										26,920
Accrued interest										$ 4,255
Debt converted into shares | shares										26,398,704
Conversion price per share | $ / shares										$ 0.0015
Convertible Promissory Note [Member] | JSJ Investments, Inc [Member]
Debt principal amount		$ 108,000
Purchase price		$ 100,000
Debt interest rate		10.00%
Debt maturity date		Sep. 28, 2021
Trading days | Trading		20
Debt description		The conversion price is 60% multiplied by the lowest trading price for the common stock during the 20 trading day period ending on the latest complete trading day prior to the date of a conversion notice.
Debt interest rate increase/decrease		18.00%
Conversion price		0.60

Convertible Notes Payable - Sum

Convertible Notes Payable - Summary of Activity of Convertible Notes Payable and Convertible Debenture (Details) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Sep. 30, 2019
Debt Disclosure [Abstract]
Balance as of December 31, 2019		$ 363,769
Issuance of convertible debenture - principal amount		721,400
Issuance of convertible debenture - debt discount and original issue discount		(725,235)
Amortization of debt discount and original issue discount	$ 181,681	584,445	$ 124,660
Balance as of March 31, 2020	$ 944,379	$ 944,379

Convertible Notes Payable - Sch

Convertible Notes Payable - Schedule of Balance Convertible Debenture Outstanding (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Debt Disclosure [Abstract]
Principal amount outstanding	$ 1,784,490	$ 1,078,090
Less: Unamortized original issue discount	(53,118)	(62,779)
Less: Unamortized debt discount	(786,993)	(651,542)
Convertible note payable, net of debt discount	$ 944,379	$ 363,769

Derivative Liability (Details N

Derivative Liability (Details Narrative)	9 Months Ended
	Sep. 30, 2020USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Origination interest on derivative liability and expensed on origination	$ 440,182

Derivative Liability - Schedule

Derivative Liability - Schedule of Conversion Feature of Derivative Liability (Details)	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Risk-Free Interest Rate [Member]
Debt measurement input percentage	0.39
Risk-Free Interest Rate [Member] | Warrants [Member]
Debt measurement input percentage		2.11
Risk-Free Interest Rate [Member] | Tranche 1 [Member]
Debt measurement input percentage		2.11
Risk-Free Interest Rate [Member] | Tranche 2 [Member]
Debt measurement input percentage		1.75
Risk-Free Interest Rate [Member] | Tranche 3 [Member]
Debt measurement input percentage		1.67
Expected Term [Member]
Debt measurement input term	11 months 15 days
Expected Term [Member] | Warrants [Member]
Debt measurement input term		1 year 2 months 30 days
Expected Term [Member] | Tranche 1 [Member]
Debt measurement input term		1 year 2 months 30 days
Expected Term [Member] | Tranche 2 [Member]
Debt measurement input term		1 year 11 days
Expected Term [Member] | Tranche 3 [Member]
Debt measurement input term		10 months 21 days
Expected Volatility [Member]
Debt measurement input percentage	191.1
Expected Volatility [Member] | Warrants [Member]
Debt measurement input percentage		312.4
Expected Volatility [Member] | Tranche 1 [Member]
Debt measurement input percentage		312.4
Expected Volatility [Member] | Tranche 2 [Member]
Debt measurement input percentage		303.70
Expected Volatility [Member] | Tranche 3 [Member]
Debt measurement input percentage		326.88
Expected Dividend Yield [Member]
Debt measurement input percentage	0
Expected Dividend Yield [Member] | Warrants [Member]
Debt measurement input percentage		0
Expected Dividend Yield [Member] | Tranche 1 [Member]
Debt measurement input percentage		0
Expected Dividend Yield [Member] | Tranche 2 [Member]
Debt measurement input percentage		0
Expected Dividend Yield [Member] | Tranche 3 [Member]
Debt measurement input percentage		0
Exercise Price of Underlying Common Shares [Member]
Debt measurement input percentage	0.01
Exercise Price of Underlying Common Shares [Member] | Warrants [Member]
Debt measurement input percentage		0.08
Exercise Price of Underlying Common Shares [Member] | Tranche 1 [Member]
Debt measurement input percentage		0.09
Exercise Price of Underlying Common Shares [Member] | Tranche 2 [Member]
Debt measurement input percentage		0.04
Exercise Price of Underlying Common Shares [Member] | Tranche 3 [Member]
Debt measurement input percentage		0.04

Derivative Liability - Schedu_2

Derivative Liability - Schedule of Derivative Liability Activity (Details)	9 Months Ended
	Sep. 30, 2020USD ($)
Balance as of December 31, 2019	$ 1,111,879
Initial fair value on issuance of convertible debenture	1,039,620
Debenture conversions	(21,296)
New warrant issuances	39,690
Common stock warrant exercises	(72,244)
Change in fair value of derivative liability	(805,917)
Balance as of September 30, 2020	1,291,732
Debenture [Member]
Balance as of December 31, 2019	1,047,977
Initial fair value on issuance of convertible debenture	1,039,620
Debenture conversions	(21,296)
New warrant issuances
Common stock warrant exercises
Change in fair value of derivative liability	(774,569)
Balance as of September 30, 2020	1,291,732
Warrants [Member]
Balance as of December 31, 2019	63,902
Initial fair value on issuance of convertible debenture
Debenture conversions
New warrant issuances	39,690
Common stock warrant exercises	(72,244)
Change in fair value of derivative liability	(31,348)
Balance as of September 30, 2020

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit) (Details Narrative) - USD ($)	Jun. 04, 2019	Mar. 29, 2019	Sep. 30, 2020	May 31, 2020	Apr. 30, 2020	Mar. 31, 2020	Jan. 31, 2020	Apr. 30, 2019	Mar. 31, 2019	Feb. 28, 2019	Jan. 31, 2019	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Number of shares of common stock									8,600,298
Share issued for services, value															$ 562,901
Exercise of stock options														$ 10,400	$ 5,000
Number of common stock warrants exercises														4,170,000
Number of stock issued upon conversion			2,083,333												427,500
Number of stock issued upon conversion, value			$ 15,000									$ 36,295	$ 46,047	$ 36,295	$ 46,047
Preferred stock dividend												$ 1,725	$ 8,338	$ 6,038	$ 8,338
Number of exercise of common stock warrants															1,405,000
Series B Preferred Stock [Member]
Number of shares of common stock					958,333
Number of shares issued for services
Share issued for services, value
Common shares issued for services and compensation, shares
Conversion of Series B preferred stock for common shares					25,000								(100,000)	(25,000)	(25,000)
Number of options exercised
Exercise of stock options
Number of stock issued upon conversion
Number of stock issued upon conversion, value
Preferred stock dividend
Series C Preferred Stock [Member]
Number of shares issued for services
Share issued for services, value
Common shares issued for services and compensation, shares
Conversion of Series B preferred stock for common shares
Number of options exercised
Exercise of stock options
Number of stock issued upon conversion
Number of stock issued upon conversion, value
Preferred stock dividend
Series B Convertible Preferred Stock [Member]
Preferred stock dividend														$ 10,350
Common Stock [Member]
Number of shares of common stock					90,126				8,600,298
Number of shares issued for services															5,250,000
Share issued for services, value															$ 5,250
Common shares issued for services and compensation, shares														16,279,273
Conversion of Series B preferred stock for common shares													734,918	958,333	734,918
Number of options exercised														4,000,000	500,000
Exercise of stock options														$ 4,000	$ 500
Number of stock issued upon conversion												2,083,333	427,500	2,083,333	427,500
Number of stock issued upon conversion, value												$ 2,083	$ 427	$ 2,083	$ 427
Preferred stock dividend
Bridge Noteholder [Member]
Number of shares of common stock							294,994
Consultant [Member]
Number of shares of common stock										250,000
Number of shares issued for services														10,052,318
Share issued for services, value										$ 7,500				$ 459,417
Number of options exercised										500,000
Exercise of stock options										$ 5,000
Consultant [Member] | Restricted Common Stock [Member]
Number of shares issued for services										750,000
Durwood Orlando Reece [Member]
Number of shares of common stock						1,000,000
Common shares issued for services and compensation, shares				11,942,161
Executive Officers [Member]
Number of shares issued for services				12,889,267
Share issued for services, value				$ 139,215
Option Holders [Member]
Number of options exercised														4,000,000
Stock options exercised price			$ 0.0026									$ 0.0026		$ 0.0026
Exercise of stock options														$ 10,400
Five Unrelated Individuals [Member]
Number of shares of common stock								5,000,000	5,000,000
Lender [Member]
Number of shares of common stock														26,586,204
Securities Exchange Agreement [Member] | Series C Preferred Stock [Member]
Number of shares of common stock	129,559
Shares issued transaction	129,558,574
Securities Exchange Agreement [Member] | LGBT Loyalty LLC [Member]
Number of restricted common stock, shares											120,959,996
Common stock, issued and outstanding percentage											49.99%
Securities Exchange Agreement [Member] | Maxim Partners, LLC [Member]
Number of stock issued upon conversion		8,598,578
Number of stock issued upon conversion, value		$ 388,675

Options and Warrants (Details N

Options and Warrants (Details Narrative) - USD ($)	Jan. 25, 2019	Aug. 31, 2020	May 31, 2020	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Stock based compensation expense
Number of warrants exercised					4,170,000
Grant and exercise of warrants					2,285,000
Proceeds from warrant exercises					$ 93,342	$ 51,569
Shares of common stock				8,600,298
Auctus Note [Member]
Shares of common stock		7,500,000
Exercise price of warrants		$ 0.15
Board Members [Member]
Number of warrants cancelled			7,000,000
Two Company Executives [Member]
Warrants issued in exchange for cancellation of salary and interest accruals	$ 348,312
2012 Equity Incentive Plan [Member]
Options outstanding					1,800,000		5,800,000

Options and Warrants - Summary

Options and Warrants - Summary of Warrant Activity (Details)	9 Months Ended
	Sep. 30, 2020$ / sharesshares
Warrants, Granted	2,285,000
Warrant [Member]
Warrants Outstanding beginning balance	8,885,000
Warrants, Granted	9,785,000
Warrants, Exercised	(4,170,000)
Warrants, Forfeited	(7,000,000)
Warrants Outstanding ending balance	7,500,000
Weighted Average Exercise Price beginning balance | $ / shares	$ 0.04
Weighted Average Exercise Price, Granted | $ / shares	0.03
Weighted Average Exercise Price, Exercised | $ / shares	0.08
Weighted Average Exercise Price, Forfeited | $ / shares	0.03
Weighted Average Exercise Price ending balance | $ / shares	$ 0.02

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	1 Months Ended				9 Months Ended
	May 31, 2020	Mar. 31, 2020	Apr. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	Dec. 31, 2018
Proceeds short-term promissory notes with related parties					$ 48,675
Number of shares of common stock				8,600,298
Accrued salaries								$ 348,312
Common shares issued to board of directors					232,394
Stock compensation expense					213,276	$ 562,901
Accrued directors' compensation					50,834		$ 80,000
Other receivables related parties					100,000		100,000
Officers and Executive Director [Member]
Accrued salaries					$ 193,552		$ 91,352
Board of Directors [Member]
Common shares issued to board of directors, shares	3,942,161
Common shares issued for services and compensation, shares	11,942,161
Annual compenation shares	8,000,000
Number of warrants cancelled	7,000,000
Shares issued and warrant modification	$ 214,595
Board of Directors [Member] | Orlando Reece [Member]
Common shares issued to board of directors, shares		1,000,000
Common shares issued to board of directors		$ 17,800
Five Unrelated Individuals [Member]
Number of shares of common stock			5,000,000	5,000,000
Stock compensation expense			$ 555,401	$ 555,401

Subsequent Events (Details Narr

Subsequent Events (Details Narrative)	Oct. 08, 2020USD ($)Trading$ / sharesshares	Oct. 31, 2020USD ($)shares	Sep. 30, 2020USD ($)$ / sharesshares	Sep. 30, 2020USD ($)$ / shares	Sep. 30, 2019USD ($)	Sep. 30, 2020USD ($)$ / shares	Sep. 30, 2019USD ($)shares	Dec. 31, 2019USD ($)$ / shares
Number of stock issued upon conversion | shares			2,083,333				427,500
Number of stock issued upon conversion, value			$ 15,000	$ 36,295	$ 46,047	$ 36,295	$ 46,047
Principal amount			$ 1,784,490	$ 1,784,490		$ 1,784,490		$ 1,078,090
Common stock par value | $ / shares			$ 0.001	$ 0.001		$ 0.001		$ 0.001
Subsequent Event [Member]
Number of stock issued upon conversion | shares		16,718,951
Number of stock issued upon conversion, value		$ 74,700
Subsequent Event [Member] | Securities Purchase Agreement [Member]
Purchase price	$ 300,000
Principal amount	$ 300,000
Common stock par value | $ / shares	$ 0.001
Debt interest rate	12.00%
Debt maturity date	Oct. 8, 2021
Trading days | Trading	5
Subsequent Event [Member] | Securities Purchase Agreement [Member] | Warrant A [Member]
Warrants to purchase | shares	100,000,000
Warrants exercise price | $ / shares	$ 0.015
Subsequent Event [Member] | Securities Purchase Agreement [Member] | Warrant B [Member]
Warrants to purchase | shares	100,000,000
Warrants exercise price | $ / shares	$ 0.015